SCHEMBL8245341

SCHEMBL8245341

CSCCC(NC(=O)OC(C)(C)C)C(=O)C1CCCCC1

nearest known ligand 0.54

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.54
CTSS P25774 3/20 0.54
CTSK P43235 3/20 0.54
HDAC4 P56524 1/20 0.46
HDAC1 Q13547 1/20 0.46
HDAC6 Q9UBN7 1/20 0.46
KLK7 P49862 1/20 0.43
LMNA P02545 1/20 0.43
POLB P06746 1/20 0.43
CA2 P00918 1/20 0.43
KLK5 Q9Y337 1/20 0.41
ITGB3 P05106 4/20 0.41
ITGA2B P08514 4/20 0.41
EPHX2 P34913 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
CACNA1B Q00975 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8245338 1.00 TSHR (0.54) TSHRCTSSCTSKHDAC4HDAC1
SCHEMBL5218978 0.82 HDAC4 (0.68) TSHRCTSSCTSKHDAC4HDAC1
SCHEMBL8252545 0.82 CTSK (0.52) TSHRCTSSCTSKHDAC4HDAC1
SCHEMBL8252549 0.82 CTSK (0.52) TSHRCTSSCTSKHDAC4HDAC1
SCHEMBL6207008 0.82 HDAC4 (0.68) TSHRCTSSCTSKHDAC4HDAC1
SCHEMBL4730477 0.82 ITGB3 (0.48) TSHRCTSSCTSKHDAC4HDAC1
SCHEMBL28740619 0.81 LMNA (0.58) TSHRCTSSCTSKHDAC4HDAC1
Cyclohexylamine SCHEMBL28856746 0.81 CTSS (0.54) TSHRCTSSCTSKHDAC4HDAC1
SCHEMBL11249810 0.81 LMNA (0.58) TSHRCTSSCTSKHDAC4HDAC1
SCHEMBL7260228 0.81 LMNA (0.58) TSHRCTSSCTSKHDAC4HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1054865-A1 FARNESYL TRANSFERASE INHIBITORS AstraZeneca UK Limited (GB) 2000-11-29 EP disclosed
WO-1999041235-A1 FARNESYL TRANSFERASE INHIBITORS ASTRAZENECA UK LIMITED (GB) 1999-08-19 WO disclosed